Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Cardiovascular Morbidity and Safety in Women Treated With Mirabegron for Overactive Bladder

NCT02622555 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02622555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Cardiovascular Morbidity and Safety in Women Treated With Mirabegron for Overactive Bladder
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
November 30, 2015
Enrollment
221 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder